Reaction

Activation Syndrome reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 345 reports · 7 co-occurring drugs

As of the last recalculation, Activation Syndrome appears in 345 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is LURASIDONE HYDROCHLORIDE (PRR 105.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Lurasidone Hydrochloride33105.1105.3
Paroxetine Hydrochloride6956.957.0
Brexpiprazole1453.053.0
Guanfacine646.846.8
Vortioxetine1244.044.1
Cariprazine639.639.6
Asenapine Maleate428.228.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.